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Neurocysticercosis is the most common parasitic infection in the 
central nervous system. This disease is presented when a person 
ingests Taenia solium eggs excreted in feces from another individual 
infected with taeniasis. In 50% of the cases, neurocysticercosis takes 
place in the brain parenchyma, and its appearance is less frequent in 
the posterior fossa and the spinal cord.
The case of a patient with an atypical location of the parasite at 
the medulla oblongata, between parenchymal and spinal areas, is 
presented. The initial symptoms were common but its subsequent 
manifestations were similar to those of Bruns syndrome. Furthermore, 
the epidemiological profile of neurocysticercosis in Colombia, its 
control measures and prevention strategies were reviewed in this study.
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| Resumen |
La neurocisticercosis es la infección parasitaria más frecuente en 
el sistema nervioso central; esta enfermedad se desarrolla cuando 
los huevos de Taenia solium excretados en heces de un individuo 
con teniasis son ingeridos por otra persona. La presentación de la 
neurocisticercosis tiene lugar en el parénquima cerebral en 50% de 
los casos, mientras que en la fosa posterior y en la médula espinal 
es menos frecuente. 
Se presenta el caso de un paciente que tuvo una ubicación exótica 
del parásito a nivel del bulbo raquídeo concomitando con la forma 
parenquimatosa y medular; las manifestaciones clínicas iniciales 
fueron las comunes, pero sus síntomas posteriores se caracterizaron 
por el síndrome de Bruns. Además, durante la investigación se 
revisó el perfil epidemiológico de la neurocisticercosis en Colombia 
y las medidas de control y de prevención.
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Introduction
The most common parasitic infection of the central nervous system 
(CNS) is neurocysticercosis (NCC), caused by the larvae of the Taenia 
solium (1). In developing countries, there is a 90% prevalence 
of cases in which this disease is neglected (2), but due to the 
ease and accessibility of transportation and the large groups of 
migrant population, this disease can also be found in developed 
countries (3,4). The World Health Organization (WHO) considers 
cysticercosis as a serious public health issue (5,6). This infection 
appears in the brain parenchyma in 50% of cases, and less frequently, 
in intraventricular, subarachnoid, eye and cord areas (6). 
The case described in this research presents an unusual appearance 
in the medulla oblongata, along with the parenchymal and spinal 
form. NCC symptoms are very diverse, including, among the most 
frequently observed and described by the authors, headaches and 
convulsions (7). 80% of infections are completely asymptomatic 
and when symptoms arise, they are non-specific depending on 
the number of injuries, the development stage of the cysticercus 
and the larval location (8). The presence of cysticerci in the brain 
may be prolonged —10 to 20 years in asymptomatic state— (9,10) 
although, in many occasions, when headaches occur, this symptom 
is not considered important. The diagnosis of NCC is often confused 
with incidentaloma.
The characterization of the patient was made based on neurological 
manifestations such as focal seizures and signs of intracranial 
hypertension. Neuroimaging, initially obtained through computerized 
axial tomography scan (CT scan) and head magnetic resonance 
imaging (HMRI), helped identifying different forms of NCC.
The objectives of this paper are to present an unusual form of 
neurocysticercosis in the medulla oblongata and, thus, to provide 
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the scientific community with information about the location and 
heterogeneous behavior of the larva of T. solium.
Case presentation
A male patient, 37 years old, from Popayán, Cauca, farmer without 
history of chronic non-communicable diseases, who denies prior 
neurological abnormalities and family history of importance, was 
admitted in Hospital Universitario San José from Popayán, on February 
25, 2014, with an eight-month clinical history of neck pain treated with 
analgesics with partial response. The assessment by neurosurgery and 
pain medicine suggested that the patient had a chronic degenerative pain 
syndrome, with C5 and C6 discopathy. Algesiology delivers lumbar 
sympathetic block and epidural steroid; however, this procedure is not 
performed because the patient felt drowsy.
The neurological assessment found a patient with pain in 
the posterior cervical region, permanent headache, stiff neck, 
discreet meningeal stripe, hyperesthesia in eyeballs and drowsiness. 
ELISA technique was initially indicated for T. solium, as well as a 
complete blood count reporting reactivity and marked eosinophilia, 
respectively; also, a brain CT with contrast was requested, 
which showed a cystic image located in the left Sylvian fissure. 
Considering personal history and the regional epidemiology, in 
addition to the clinical manifestations and the report of the TAC, 
treatment against NCC with albendazole 200mg every 12 hours, 
dexamethasone 8mg every hour, and phenytoin 100mg every 12 
hours was begun.
Eleven days after admission, a second brain CT showed 
supratentorial hydrocephalus, megacisterna magna and three 
scattered calcifications in both cerebral hemispheres (Figure 1 and 2).
Figure 1. Computerized axial tomography scan which allows observing calcifications that suggest the effects of neuro-
cysticercosis. Source: Own elaboration based on the data obtained in the study.
Figure 2. Computerized axial tomography scan which allows observing, from top to bottom, calcifications, cystic image 
located in the left Sylvian fissure compatible with neurocysticercosis in vesicular phase and megacisterna magna. Source: 
Own elaboration based on the data obtained in the study.
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The patient reported improvement after 12 days of treatment with 
albendazole, however, he experienced sporadic crisis of headaches, 
vomiting and drowsiness. Neurological examination determined 
predominantly left hypotonia and muscle stretch reflexes showed 
hyperreflexia in lower extremities. Since the patient could not walk 
on his own, possibly due to subsequent involvement of the posterior 
cords, cysticercosis related injury in the posterior fossa is discarded 
and a simple and contrast HMRI was requested. 
Deworming was completed after 26 days of admission in the 
service. Although the evolution of the patient indicated improvement, 
headaches did not diminish. Finally, a HMRI was taken, showing, on 
the one hand, two hyperintense punctiform images of corticosubcortical 
location in the left frontal region and towards the ipsilateral Sylvian 
fissure compatible with residual calcifications, and, on the other, 
a rounded cystic image, with intermediate signal intensity and 
hyperintense with walls that enhance the lateral contrast and apparent 
contact with the medulla oblongata on the left side, which was about 
6x3mm long (Figure 3).
(12). Hence the importance of recognizing the biology of CTC when 
applying control and prevention measures in the population.
The manifestations and findings of cerebellar dysfunction are the 
key factors of this case: the holocraneal headache with persistent (and 
occasional projectile) vomiting, alongside ataxia with lateropulsion 
to the left that compromised gait and resulted incapacitating —which 
constitutes the most frequent alteration that indicates cerebellar 
dysfunction— the initial hypotonia worsened to such an extent 
that supine position could not be sustained and the patient chose 
left lateral decubitus position, signs of leg length discrepancy, 
dysdiadochokinesia and non-fluid language. 
All signs indicated that the patient suffered a supra and 
infratentorial lesion, therefore, a BMRI was required. An ELISA 
test for T. solium helped confirming the infection and neuroimaging 
was useful to classify various stages of cysticercosis: vesicular, 
colloidal, granular and nodular (calcification) (12).
During the course of the disease, the patient had critical days with 
acute headache, dizziness, complete abnormal gait due to ataxia and 
lateralization with compromised state of consciousness, manifestations 
explained by Bruns syndrome (13-15).
In 1902, Bruns described ataxia caused by frontal lesions, 
similar to what was observed in diseases of the cerebellum that 
fundamentally compromised statics, lateropulsion and retropulsion 
of gait originated by a malfunction of the fronto-ponto-cerebellar 
tract (16-19). Bruns syndrome is typically characterized by episodes 
of severe headache, vomiting and associated vertigo related to 
sudden changes in head position that may persist for a few minutes 
to an hour and, sometimes, cause sudden death.
Epidemiology
NCC is considered the leading cause of acquired epilepsy and 
hydrocephalus (15) in adults from countries in South Asia, Mexico, 
Colombia, Ecuador, Peru, among others (20-22). Colombia does 
not have clear studies for the whole country; there are reports by 
Universidad Industrial de Santander, Universidad de Caldas (23) 
and a study conducted in Boyacá (24), all of them showing different 
figures. 
In 2004, in the Department of Cauca, an epidemiological profile 
of human cysticercosis in five first level hospitals reported a total of 
55.2% in the department out of a population of 433 patients (11). 
This result surpassed the study conducted in Vaupés, whose figures 
are considered the highest in Colombia (38.7%) (25). Given this 
situation, it is necessary to conduct studies that are valid for the 
entire national territory.
Control measures and prevention
A disease like NCC involves cultural and socioeconomic aspects of 
human groups, especially when considering that mechanisms of 
propagation and perpetuation of infection are not overcome due to 
the customs of the people living in endemic areas. There is no doubt 
that proper handwashing before and after food consumption, control 
of environmental sanitation, proper disposal of feces, adequate water 
service to ensure potable water, among others, are the best means 
to prevent, control and cure patients with taeniasis-cysticercosis 
complex (26-28). Even though pork, when the animal is not raised 
with hygienic standards, is one of the main sources of T. solium, 
irrigation of vegetables and fruits with polluted water may also 
contribute to the development of CTC, hence the importance of 
knowing the life cycle of the parasite (12).
Figure 3. Head magnetic resonance imaging showing a cystic lesion adjacent 
to the medulla oblongata. Source: Own elaboration based on the data obtained 
in the study.
The results of the studies concluded a cystic lesion adjacent to the 
medulla oblongata and enhancement of the walls that, in association 
with chambered images of multicystic appearance in the subarachnoid 
space of the posterior fossa and cortico-subcortical calcifications, 
lead to discard NCC (Figure 3). The patient progressed satisfactorily 
with complete improvement of the symptoms and was discharged 
without complications.
Treatment
The patient was treated with cysticidal drugs that are currently 
recommended by experts in parasitology, infectious diseases and 
neurology. Epilepsy was controlled using phenytoin sodium, which 
allowed a gradual improvement.
Discussion
Finding neurocysticercosis manifestations in inhabitants of endemic 
areas consulting for severe headache and developing signs of 
intracranial hypertension is not uncommon taking into account that the 
highest national prevalence of this disease is found in the department 
of Cauca (55.2%) (11). The taeniasis-cysticercosis complex (CTC) 
is caused by the pork tapeworm known as T. solium, which affects 
humans after eating their eggs, while NCC is the most common CNS 
helminths and the leading cause of acquired epilepsy in the world 
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Conclusions
A comprehensive analysis of the patient is essential to establish an 
accurate diagnosis and determine treatment. The description of this 
case shows an atypical manifestation of the larva of T. solium, which 
should always be considered within the diagnostic possibilities 
currently obtained through the use of imaging tools such as CT or 
HMRI, the detection of antibodies and other laboratory tests. NCC 
requires immediate and complete cysticidal treatment managed at 
hospitals to achieve full eradication of the larvae and prevent future 
recurrences and/or sequelae.
NCC is a chronic disease of the CNS that deserves attention; 
the WHO considers this condition as a public health problem, 
reason why healthy habits that improve eating behaviors should 
be taught to avoid infection, since this is a completely preventable 
disease. 
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